Hitoji Uchiyama Selected Research

Hitoji Uchiyama Research Topics

Disease

18	Multiple Myeloma 12/2023 - 04/2009
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 12/2008
7	Neoplasms (Cancer) 01/2023 - 04/2009
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 01/2018
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 04/2009
3	Thrombocytopenia (Thrombopenia) 02/2024 - 01/2011
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 01/2014
3	Anemia 09/2023 - 01/2009
3	Lymphoma (Lymphomas) 01/2021 - 05/2020
3	Fever (Fevers) 05/2020 - 01/2012
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 04/2009
3	Leukemia 10/2015 - 04/2009
2	COVID-19 12/2023 - 01/2023
2	Frailty 03/2022 - 01/2022
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2021 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 07/2019
2	Aplastic Anemia (Anemia, Hypoplastic) 03/2019 - 01/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 02/2019 - 01/2012
2	Lymphadenopathy 01/2018 - 01/2012
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018 - 01/2011
2	Philadelphia Chromosome 10/2015 - 12/2008
2	Disseminated Intravascular Coagulation 01/2012 - 01/2011
1	Cytopenia 02/2024
1	Thrombotic Thrombocytopenic Purpura 03/2023
1	Gastrointestinal Hemorrhage (Hematochezia) 03/2023
1	Purpura 03/2023
1	Epistaxis (Nosebleed) 03/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Hypoalbuminemia 01/2022
1	Pemphigus (Pemphigus Vulgaris) 01/2022
1	Bronchiolitis Obliterans 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2020
1	Vomiting 05/2020
1	Guillain-Barre Syndrome 05/2020
1	Neutropenia 05/2020
1	Pain (Aches) 05/2020
1	Infections 05/2020
1	Respiratory Insufficiency (Respiratory Failure) 05/2020
1	Serositis 01/2020
1	Acute Promyelocytic Leukemia 01/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020
1	Carcinogenesis 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2019
1	Pneumonia (Pneumonitis) 10/2018

Drug/Important Bio-Agent (IBA)

11	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2010
7	Rituximab (Mabthera)FDA Link 01/2023 - 06/2015
7	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2015
6	Bortezomib (Velcade)FDA Link 01/2022 - 11/2010
4	carfilzomibIBA 03/2022 - 01/2022
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 07/2009
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019 - 01/2011
2	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 09/2023
2	Serum AlbuminIBA 09/2023 - 01/2022
2	obinutuzumabIBA 01/2023 - 01/2022
2	Bendamustine Hydrochloride FDA Link 01/2022 - 07/2019
2	Methotrexate (Mexate)FDA LinkGeneric 11/2021 - 03/2010
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 07/2009
2	Phosphotransferases (Kinase)IBA 11/2019 - 10/2018
2	thymoglobulin FDA Link 03/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 01/2018
2	Dasatinib (BMS 354825)FDA Link 10/2015 - 04/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015 - 10/2013
2	Methylprednisolone FDA LinkGeneric 06/2015 - 01/2011
2	Alkylating AgentsIBA 01/2012 - 01/2011
2	Dacarbazine (DIC)FDA LinkGeneric 01/2011 - 04/2009
1	Bispecific AntibodiesIBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	VaccinesIBA 12/2023
1	Messenger RNA (mRNA)IBA 12/2023
1	CholesterolIBA 09/2023
1	von Willebrand FactorIBA 03/2023
1	caplacizumabIBA 03/2023
1	Alanine Transaminase (SGPT)IBA 03/2023
1	elotuzumabIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	CCAAT-Enhancer-Binding Protein-alphaIBA 11/2022
1	Proteasome InhibitorsIBA 01/2022
1	daratumumabIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	iguratimodIBA 11/2021
1	ixazomibIBA 04/2021
1	Glycophorins (Glycophorin C)IBA 01/2021
1	anti-small nuclear ribonucleoproteins autoantibodiesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	NucleophosminIBA 10/2018

Therapy/Procedure

22	Therapeutics 03/2024 - 07/2004
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
10	Stem Cell Transplantation 01/2021 - 04/2008
3	Transplantation 02/2024 - 11/2010
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2010 - 01/2009
2	Hematopoietic Stem Cell Transplantation 08/2022 - 01/2009
2	Cell Transplantation 07/2020 - 01/2020
2	Renal Dialysis (Hemodialysis) 01/2011 - 01/2009
1	Critical Care (Surgical Intensive Care) 05/2020
1	Complementary Therapies (Alternative Medicine) 02/2019